(32) showed that EVI1 plays an important role in the key properties of AML leukemic stem cells, and all-trans retinoic acid (ATRA) enhances the effects of EVI1 on AML stemness, thus, raising the possibility of using RAR antagonists in the therapy of EVI1high AML. This evidence concerns the gene MECOM and acute myeloid leukemia.